Details for Product No. ABIN412149
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Functional Studies (Func), Cell Culture (CC)
Pubmed 4 references available
Catalog no. ABIN412149
Quantity 1 g
357.50 $   Plus shipping costs $45.00
Shipping to United States (Change)
Availability Will be delivered in 2 to 3 Business Days

Order hotline:

  • +1 404 474 4654
  • +1 888 205 9894 (TF)
Characteristics Celecoxib is a highly selective COX-2 inhibitor and primarily inhibits prostaglandin production. Celecoxib is approximately 7.6-fold more selective for COX-2 inhibition over COX-1.This specificity allows celecoxib to reduce inflammation and pain while minimizing gastrointestinal adverse drug reactions that are common with non-selective non-steroidal anti-inflammatory drugs.
Purity 99,00%
Molecular Weight 381.37 Da
CAS-No 169590-42-5
Restrictions For Research Use only
Format Solid
Reconstitution Solubility: Soluble in DMSO (200 mg/mL), ethanol (100 mg/mL), Poorly soluble in water.
Handling Advice Protect from light and air.
Storage -20 °C
Expiry Date 24 months
Supplier Images
Celecoxib Celecoxib
Product cited in: Kwon, Lee, So et al.: "Generation of regulatory dendritic cells and CD4+Foxp3+ T cells by probiotics administration suppresses immune disorders." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 107, Issue 5, pp. 2159-64, 2010 (PubMed).

Fujita, Kohanbash, Fellows-Mayle et al.: "COX-2 blockade suppresses gliomagenesis by inhibiting myeloid-derived suppressor cells." in: Cancer research, Vol. 71, Issue 7, pp. 2664-74, 2011 (PubMed).

Obermajer, Muthuswamy, Lesnock et al.: "Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells toward stable myeloid-derived suppressor cells." in: Blood, Vol. 118, Issue 20, pp. 5498-505, 2011 (PubMed).

Tasaki, Yamamoto, Omura et al.: "Oxicam structure in non-steroidal anti-inflammatory drugs is essential to exhibit Akt-mediated neuroprotection against 1-methyl-4-phenyl pyridinium-induced cytotoxicity." in: European journal of pharmacology, Vol. 676, Issue 1-3, pp. 57-63, 2012 (PubMed).

back to top